ArticlePharmaceutical research2019

Knockdown of Orphan Transporter SLC22A18 Impairs Lipid Metabolism and Increases Invasiveness of HepG2 Cells.

Shingo Ito et al.PubMed ↗Publisher ↗

No numbers read from the abstract.